Skip to main content

Basic Science Representative on PRS

October 4, 2019
1 min read

MIRI PI Perrie O’Tierney-Ginn, PhD, was elected to the Perinatal Research Society (PRS) council as their Basic Science representative for 2019-2021.

Perrie O’Tierney-Ginn, PhD

MIRI Principal Investigator Perrie O’Tierney-Ginn, PhD, was elected to the Perinatal Research Society (PRS) council as their Basic Science representative for 2019-2021. As the mission statement of PRS notes, it was “established in 1969 to foster scientific interchange and communication among neonatologists, obstetricians and basic scientists whose research interests were in the area of perinatal medicine and developmental biology.

The PRS is unique in that they target their membership to equally balance the specialties represented in them: one-third neonatologists; one-third obstetricians; and one-third basic scientists. “This focus on the balance and interaction between these fields makes this a natural scientific home for me, as a Mother Infant Research Institute investigator, and I feel quite honored to be elected to represent basic scientists on the PRS Council,” Dr. O’Tierney-Ginn said. Her overall research interest is to understand the effect of the maternal nutritional environment (metabolism, diet, body composition) on placental function and fetal nutrient delivery and growth.

Pregnant woman grocery shopping
Articles
10 Foods That Support a Healthy Pregnancy
May 22, 2026
Check out the 10 healthy foods to eat during pregnancy, plus expert nutrition advice on cravings, nausea, diet soda and prenatal health.
Doctor taking blood pressure
Articles
Why Is High Blood Pressure Still So Hard To Control? Tufts Medicine Researchers Take a Closer Look
May 7, 2026
Despite decades of progress in diagnosis and treatment, high blood pressure remains one of the most common, and most difficult to control, health conditions worldwide. A new review from Tufts Medical Center explores why, and what can be done to change it.
Katina Robison, MD, and Don S. Dizon, MD
Articles
New Clinical Trial at Tufts Medicine Aims to Ease Vaginal Side Effects of Breast Cancer Treatment
May 6, 2026
A Tufts Medicine clinical trial is studying vaginal laser therapy to help breast cancer survivors manage dryness and discomfort after treatment.

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top